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BRIEF EPIDEMIOLOGY OF LUNG CANCER
Although lung cancer incidence rates started to slowly decrease for men in the 1980s
followed by declining incidence rates for women in the late 1990s,1 lung and bronchus
cancer remain the leading cause of cancer mortality in the United States, with an estimated
87,750 and 72,590 deaths predicted to occur in men and women, respectively, in 2012.2
Globally, approximately 75% of lung cancer cases are attributable in part to smoking
tobacco, with a higher estimate of 85% to 90% for the United States.3–6 Of note, women are
more likely than men to have nonsmoking-related lung cancer.7,8 In a study of 6 large
prospective epidemiologic cohort studies primarily performed in the United States, Wakelee
and colleagues8 found that the age-adjusted lung cancer incidence rates for individuals 40 to
79 years of age who never smoked ranged from 14.4 to 20.8 per 100,000 person-years in
women and 4.8 to 13.7 per 100,000 person-years in men.
Because tobacco smoking is a potent carcinogen, secondary causes of lung cancer are often
diminished in perceived importance. If considered in its own disease category, however,
lung cancer in never smokers would represent the seventh leading cause of cancer mortality
globally, surpassing cancers of the cervix, pancreas, and prostate,5 and among the top 10
causes of death in the United States.7,9 Because of the significant number of lung cancer
deaths occurring among individuals who have never smoked, it is apparent that there are
important risk factors for lung cancer other than tobacco smoking that can contribute
substantially to the lung cancer mortality in never smokers.5,7,9–12 In fact, these other lung
carcinogens often act in an additive or synergistic manner in individuals who smoke tobacco
products.13,14
In a frequently cited paper published in 1981, Doll and Peto15 estimated that occupational
exposures are responsible for 15% and 5% of lung cancer in men and women, respectively,
in the United States. The 2008 to 2009 President’s Cancer Panel Report16 indicated that the
cancer risk estimates suggested by Doll and Peto,15 as well as risk estimates from similar
© 2012 Elsevier Inc. All rights reserved.
*Corresponding author. bill-field@uiowa.edu.
Conflict of interest: No Conflicts.
NIH Public Access
Author Manuscript
Clin Chest Med. Author manuscript; available in PMC 2013 December 30.
Published in final edited form as:













studies,17,18 “are woefully out of date, given our current understanding of cancer initiation
as a complex multifactorial, multistage process.”
To complicate risk assessment further, the Panel16 pointed out that fewer than 10% of the
more than 80,000 chemicals currently in use in the United States have been evaluated for
safety. The primary objective of this article is to provide a brief overview of the
environmental and occupational lung carcinogens currently listed by the International
Agency for Research on Cancer (IARC) as known human lung carcinogens. Supplementary
new information, with a focus on analytic epidemiologic studies that have become available
since IARC’s most recent evaluation, is also discussed.
IARC GROUP 1 LUNG CARCINOGENS AND CARCINOGENIC AGENTS
The IARC prepares, with the assistance of international working groups of experts,
evaluations of carcinogenicity for a wide range of human exposures.
The IARC classifies agents as follows:
• Carcinogenic to humans (Group 1)
• Probably carcinogenic to humans (Group 2A)
• Possibly carcinogenic to humans (Group 2B)
• Not classifiable as to its carcinogenicity to humans (Group 3)
• Probably not carcinogenic to humans (Group 4)
Agents classified as known Group 1 lung carcinogens are listed in Table 1 and include the
categories of ionizing radiation, chemicals and mixtures, occupational exposures, metals,
dust and fibers, personal habits, and other exposures. Starting in 2009, several IARC panels
reassessed the carcinogenicity of Group 1 agents in each of the categories listed. The
assessments were published in 2012 as Volume 100 C through F of the IARC Monographs,
see http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php.
One of the agents, indoor emissions from household combustion (eg, coal), is predominantly
an environmental lung carcinogen; 16 agents are primarily occupational lung carcinogens
(although environmental exposures occur); and 8 agents are both potential environmental
and occupational lung carcinogens. For purposes of this overview on occupational and
environmental lung carcinogens, the chemotherapy regimen of mechlorethamine, oncovin,
procarbazine, and prednisone (MOPP), which was developed in the 1960s to treat Hodgkin
lymphoma,19 as well as the well-known IARC Group 1 carcinogens (tobacco smoking,
indoor emissions from household combustion [eg, coal], and secondhand tobacco smoke,
also referred to as environmental tobacco smoke), are not discussed. A detailed discussion
on secondhand smoke is presented in an earlier article by Dela Cruz and colleagues14 in this
journal. Discussion concerning the health effects of tobacco smoking14,20 are limited to
describing selected interactions with other lung carcinogens.
IARC Group 1 Lung Carcinogens: Ionizing Radiation
All types of ionizing radiation have been documented to be carcinogenic to humans (ie,
Group 1). The types of radiation primarily identified as lung carcinogens are α-particles, γ-
rays, and x-rays.21 Fig. 1 displays the relative contribution of the various sources of
radiation to the US population.22 Nearly half (48%) of the average individual’s radiation
exposure in the United States comes from medically related procedures, with most of the
remaining radiation exposure coming from exposure to radon-222 decay products.22
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Ionizing radiation: α-particles—All internalized radionuclides that emit α-particles,
including radon-222 decay products and plutonium-239, are classified as Group 1
carcinogens by IARC.23 Alpha-particles are somewhat unique among occupational and
environmental carcinogens, because of their ability to produce a higher relative rate of
double-strand DNA breaks compared with other types of ionizing radiation. Cells that have
been hit by an α-particle, as well as nearby cells (ie, the so-called “bystander effect”),24 may
undergo genetic changes that lead to cancer.25 Alpha-particles can also produce reactive
oxygen intermediates that can produce oxidative damage to the DNA.25 A single bronchial
epithelial cell that has sustained genetic damage can initiate lung cancer.25 Because cancer is
thought to originate from a single cell (ie, monoclonal) that has completed the process of
malignant transformation, it is unlikely a threshold exists for α-particle–induced lung
cancer.25 For additional information on the lung cancer risk posed by alpha particles, see
http://monographs.iarc.fr/ENG/Monographs/vol100D/mono100D.pdf.
Ionizing radiation (α-particles): radon-222 and its decay products: Radon-222 (radon)
and its decay products are the oldest known occupational carcinogens.26–29 Radon is a
colorless radioactive noble gas with a half-life of 3.8 days that is formed as part of the
uranium-238 decay chain.30 Because several of the radionuclides (ie, uranium-234,
thorium-230, and radium-226) between uranium-238 and radon-222 have relatively long
half-lives, there is a constant source of radon production in the ground (eg, soil, rocks,
groundwater). Although radon occurs naturally outdoors, radon can accumulate in
underground structures, such as mines, as well as built environments, such as homes,
offices, and schools.30 The potential for radon exposure varies by geographic areas (eg, see
http://www.epa.gov/radon/pdfs/zonemapcolor.pdf); however, even structures built in areas
with low radon potential can exhibit greatly elevated radon concentrations.
As radon undergoes radioactive decay, it produces a series of solid radioactive decay
products that can be inhaled. Two of the short-lived radon decay products, polonium-218
and polonium 214, deliver most of the radiation dose, via α-decay, to the bronchial epithelial
cells. Deposition of radon decay products in the lung depends on several factors, including
particle size, tidal lung volume, respiratory rate, and lung volume.25,30
The causative link between protracted radon decay product exposure and lung cancer has
been firmly documented in the numerous retrospective mortality studies of uranium and
hard rock underground miners performed throughout the world. In the late 1990s, the
National Research Council’s Biologic Effects of Ionizing Radiation (BEIR) VI Committee
pooled the raw data from 11 major retrospective mortality studies of uranium and hard rock
underground miners.25 The study included approximately 68,000 miners with 1.2 M person-
years of follow-up and more than 2700 lung cancer deaths. Each of the 11 studies reported
significantly increased lung cancer mortality with increasing exposure to radon decay
products and a synergistic (albeit sub-multiplicative) interaction between cigarette smoking
and radon decay product exposure. The BEIR VI committee also performed a subset study
of miners who had a mean radon exposure of 14.8 Working Level Months (WLMs) (14 ×
10−5 per mJ h m−3). The risk estimates for this subgroup that was exposed to radon
exposures comparable to protracted exposure at the Environmental Protection Agency’s
(EPA) action level of 4 pC/L (ie, 14.8 WLMs) were similar to the findings using the overall
pooled data set.25,31 Based on the pooled results, the International Commission on
Radiological Protection32 recently indicated that a lifetime excess absolute risk of 5 × 10−4
per WLM should be used as the nominal probability coefficient for radon progeny-induced
lung cancer.
Although Fig. 1 indicates that occupational exposure to ionizing radiation accounts for less
than 0.1% of the average individual’s radiation exposure in the United States, 30 years of
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exposure at the current Mine Safety and Health Administration’s and Occupational Safety
and Health Administration’s (OSHA) permissible exposure limit for cumulative radon decay
product exposure of 4 WLMs per year would result in a 6% increase in lifetime risk of lung
cancer.33 Since the publication of the BEIR VI report, additional miner studies have been
published that continue to support the original risk estimates from the miner cohort
studies.32–37
In addition to radon’s role as an occupational lung carcinogen, radon exposure occurring
outside the workplace also presents an important environmental lung cancer risk. Based on
projections from the radon-exposed underground miner studies, the BEIR VI Committee
estimated (ie, central risk estimate based on 2 models) that approximately 18,600 lung
cancer deaths occur each year in the United States from nonoccupational radon decay
product exposure.25 In 2003, the EPA updated the estimate to 21,100 (13.4%) of the total
157,400 lung cancer deaths that occurred in the United States in 1995.37 The EPA projected
that a lifetime exposure at the EPA’s radon action level (ie, 4 pCi/L) yields a 2.3% risk of
lung cancer for the US population overall, 4.1% for individuals who smoked at least 100
cigarettes in their lives, and 0.73% for individuals who never smoked.38
To directly examine the risk of protracted radon exposure in the residential setting, 22 major
case-control residential radon studies were performed in the late 1980s and 1990s.30,31,39–42
Two of the studies were performed in China,39 13 in Europe,40 and 7 in North America.41
Of the 22 case-control studies, 19 reported increased risk estimates at 2.7 pCi/L (100 Bq/
m3),31 which is below the EPA radon action level of 4 pCi/L. The raw data from Chinese,
North American, and European studies were pooled to increase study power. The pooled
odds ratios (ORs) at 2.7 pCi/L (100 Bq/m3) for the China, Europe, and North America case
control studies were 1.13 (95% confidence interval [CI] 1.01–1.36), 1.08 (95% CI 1.03–
1.16), and 1.11 (95% CI 1.00–1.28), respectively. After corrections for random uncertainties
in radon assessment, the OR for the European pooling increased to 1.16 (95% CI 1.05–1.31).
A similar increase in the OR was also noted for the North American pooled analyses when
data were restricted on the basis of completeness of radon measurement data. Although
other potential sources of nondifferential radon exposure misclassification could not be ruled
out, it would tend to bias the observed association toward the null (eg, the true effect is
underestimated).42
In summary, after stratification for smoking, the pooled analyses provided direct evidence of
an association between protracted residential radon exposure and lung cancer. The studies
exhibited a linear dose-response relationship with no evidence of a threshold with risk
estimates very comparable to the OR of 1.12 (95% CI 1.02–1.25) extrapolated from the
BEIR VI risk models for radon. The findings of the pooled analyses suggest that 8% to 15%
of the lung cancer risk in Europe and North America is attributable to radon decay product
exposure.41 Because of the large population at risk and the widespread potential for
protracted exposures, residential radon decay products are likely the leading environmental
cause of cancer mortality in the United States30,43 and the seventh leading cause of cancer
mortality overall (Fig. 2). For additional information on the lung cancer risk posed by radon,
see www.breathingeasier.info.
Ionizing radiation (α-particles): plutonium-239: Plutonium-239 (239Pu) is a manmade
silvery gray radioactive metal, with a 24,110-year half-life, that undergoes radioactive decay
by α-particle emission. Its primary use is in nuclear weapons and nuclear power production
(ie, mixed-oxide fuel).44 In the United States, workers involved with the chemical or
mechanical processing of plutonium for nuclear weapons production are at greatest risk of
exposure.44 The primary source of exposure for nuclear workers is inhalation of dust
contaminated with 239Pu. After inhalation of 239Pu, it is redistributed primarily to lung,
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liver, and bone.44,45 Pulmonary absorption of inhaled plutonium follows a 2-phase model
with absorption half-times of months and years.
The IARC’s 2001 evaluation of the carcinogenicity of 239Pu relied primarily on the dose-
response relationship findings45 for 239Pu exposure and lung cancer for highly exposed
workers at the Mayak Nuclear Processing Plant in the Russian Federation. Although
studies46–48 performed in the United States have only suggested increased lung cancer risk
for 239Pu-exposed workers, the causal relationship was strengthened in IARC’s 2012
evaluation,45 which reported on several follow-up studies of 239Pu-exposed Mayak workers
that incorporated improved assessment of smoking, dosimetry, and work history data.46–55
Overall, the follow-up studies reported a statistically significant dose-response relationship
between estimated 239Pu lung dose and lung cancer, with no observed departure from
linearity or threshold. The most recent follow-up study,53 published in 2008, estimated
excess relative risks for lung cancer per gray (Gy) at attained age 60 years, with adjustment
for smoking, was 7.1 (95% CI 4.9–10.0) for males and 15 (95% CI 7.6–29.0) for females.
For additional information on 239Pu, see http://monographs.iarc.fr/ENG/Mono graphs/
vol100D/mono100D.pdf.
Ionizing Radiation: X-rays and γ-Rays
A large proportion of the x-ray dose received by the average person in the United States
each year is from medically related external exposure from computed tomography (24%),
interventional fluoroscopy (7%), or conventional radiography and fluoroscopy procedures
(5%) (see Fig. 1). The percentage of the total effective dose has increased for these
procedures, as well as for nuclear medicine procedures that often use γ-ray emitting
radioisotopes (eg, inhalation of technetium-99 m for lung scans). In fact, the collective dose
received by the US population in the early 1980s was 7 times lower than in 2006.22 The low
proportion of occupational exposure (ie, <0.1%) observed in Fig. 1 reflects the low
percentage of workers in the United States who are at risk for radiation exposure (eg,
nuclear power workers, x-ray technicians), as well as the low percentage who received
recordable radiation doses.
The IARC previously classified x-rays and γ-rays as Group 1 lung carcinogens in 200023
based primarily on the findings of the Lifespan Study (LSS) of atomic bomb survivors in
Hiroshima and Nagasaki, Japan. Lung cancer was the second leading type of cancer,
following stomach cancer, in the LSS cohort. The recent 2012 IARC monograph23 continues
to update x-ray and γ-ray cancer risk estimates based primarily on findings from the LSS
cohort,56,57 as well as with supplemental findings from populations exposed to medical
procedures.58
In a more recent study, not included in the IARC review,45 that included 105,404 LSS
subjects and 1803 primary lung cancer incident cases that were identified for the period
1958 to 1999, Furukawa and colleagues59 reported that relative to individuals who never
smoked, the joint effect between radiation and smoking was super-multiplicative for light or
moderate smokers, with a rapid increase in excess risk with smoking intensity up to about 10
cigarettes per day. For smokers who smoked a pack or more per day, however, the
investigators reported the joint effect was additive or subadditive. The non–gender-specific
average excess relative risk per Gy at attained age 70 was 0.59 (95% CI 0.31–1.00) for
nonsmokers, with a female:male ratio of 3.1. The investigators concluded that the “joint
effect of smoking and radiation on lung cancer in the LSS is dependent on smoking intensity
and is best described by the generalized interaction model rather than a simple additive or
multiplicative model.” For additional information on the lung cancer risk posed by x-ray and
γ-ray exposure, see http://monographs.iarc.fr/ENG/Monographs/vol100D/index.php.
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IARC Group 1 Lung Carcinogens: Chemicals and Mixtures
Bis(chloromethyl)ether; technical-grade chloromethyl methyl ether—
Bis(chloromethyl)ether (BCME) and technical-grade chloromethyl methyl ether (CMME)
were manufactured before 1976 in the United States, but because of their lung
carcinogenicity, the use of these chemicals has been reduced substantially in the United
States.60 BCME and CMME were used as alkylating agents and chemical intermediates.
Technical-grade CMME contains 1% to 8% BCME.61 The greatest potential for past
occupational exposure to BCME or CMME was for ion-exchange resin makers, chemical
plant workers, laboratory workers, and specialty polymer makers.60
In a worker survey conducted from 1981 to 1983, the National Institute for Occupational
Safety and Health (NIOSH) estimated that a total of 14 laboratory workers were potentially
exposed to BCME.61 There was no estimate of potential exposure to CMME. In the past, a
significant potential for environmental exposure to BCME arose from the use of mosquito
coils that contain octachlorodipropyl ether, also referred to as “S-2.” Although the EPA does
not register S-2 for any current use, there have been some concerns about illegal sales of
imported mosquito coils containing S-2.62 BCME can be produced by the burning of
mosquito coils from impurities present in the S-2 or by the thermolytic degradation of S-2.63
Based on numerous studies of exposed workers, the IARC states that BCME is among the
most potent human carcinogens known. The fact that BCME and CMME are both alkylating
agents provides support that their mode of action is genotoxic. Six epidemiologic studies
performed in 1970 documented statistically significant increases in the relative risks for lung
cancer for exposures to BCME. In 4 of the studies, the primary exposure was from
technical-grade CMME with 1% to 8% contamination from BCME.64 The histologic type of
lung cancer most often associated with the exposures was small cell carcinoma.65 For
additional information on the lung cancer risk posed by BCME and CMME, see http://
monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-25.pdf.
Sulfur mustard—Sulfur mustard, called mustard gas in the military sector, is primarily a
chemical warfare agent. Occupational exposures can also occur during its storage and
destruction or from inadvertent exposure near dumping areas or areas where contamination
may have occurred in the past (eg, military installations, demolition of old buildings).
Findings from numerous studies performed between 1950 and 2000 detailing the adverse
effects of short-term battlefield exposure and prolonged exposure in chemical factories
firmly established the lung carcinogenicity of sulfur mustard.66 The genotoxicity of sulfur
mustard is primarily attributed to its behavior as a bi-functional alkylating agent.67 For
additional information on the lung cancer risk posed by sulfur mustard, see http://
monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-30.pdf.
Coal-tar pitch—Coal-tar pitch is the solid residue remaining from the distillation of coal
tars. The actual composition of coal-tar pitch depends on the source materials used that
resulted in the coal tars and the distillation temperature. Coal tars are composed primarily
(90%) of 3-membered to 7-membered polycyclic aromatic hydrocarbons (PAHs), as well as
their methylated derivative with lower concentrations of phenolic compounds and nitrogen
bases.68 Potential sources of occupational exposure to volatile PAHs (eg, acridine,
anthracene, benzo[a] pyrene, chrysene, pyrene, phenanthrene) from coal tar include foundry
and coal gasification processes and the production of coke, aluminum (eg, carbon electrode-
manufacturing), pavement tar, roofing tar, coal tar paints, sealants, and refractory bricks.68
IARC working groups that met in 2005 and again in 2009 determined that there was
sufficient evidence from epidemiologic studies of road pavers and roofers to support the
carcinogenicity of coal-tar pitch.68,69 Even though coal-tar pitch was phased out in the
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1960s and 1970s in many of the European countries where the epidemiologic studies were
performed, studies focused on the adverse health effects of bitumen exposure continue to
observe suggestive evidence of coal tar’s lung carcinogenicity.70,71 For additional
information on the lung cancer risk posed by coal tar pitch, see http://monographs.iarc.fr/
ENG/Monographs/vol100F/mono100F-17.pdf.
Soot, as found in occupational exposure of chimney sweeps—Soot is a
carbonaceous by-product material produced from the incomplete conversion of fossil fuel or
other carbon-containing material (eg, paper, plastics) to combustion products (eg, water
vapor, CO2). Soot contains up to 60% carbon, inorganic material, and a soluble fraction
consisting primarily of PAHs.72 Occupations with higher potential for soot exposure include
chimney sweeps; firefighters; brick masons and helpers; heating, ventilation, and air
conditioning personnel; and others that require work near where organic matter is burned.72
Chimney sweeps, in particular, have a high potential for exposure to soot. In 2006, there
were more than 1000 members of the National Chimney Sweep Guild, which represents
fewer than 50% of the chimney sweeps in the United States.73
Two epidemiologic studies of chimney sweeps performed in Sweden and Finland in the
1990s reported elevated lung cancer risks for chimney sweeps from soot exposure. These
studies provided the basis for the IARC to classify soot, as found in occupational exposure
of chimney sweeps, a human lung carcinogen.74 Adjustment for smoking was performed at
the group level for the Swedish study and by use of social class for the Finnish study. An
occupational cohort study by Pukkala and colleagues75 that accessed 45 years of cancer
incidence data by occupational category for individuals aged 30 to 64 years in the 1960,
1970, 1980/1981, and/or 1990 censuses provided further support that soot is a lung
carcinogen. In the study published in 2009,75 a total of 212 incident lung cancers were
observed in chimney sweeps from Denmark, Finland, Norway, and Sweden, resulting in a
standardized incidence ratio of 1.49 (95% CI 1.3–1.7) for lung cancer for chimney sweeps.
For additional information on the lung cancer risk posed by soot, see http://
monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-21.pdf.
Diesel engine exhaust—According to McDonald and colleagues,76 diesel engine
exhaust contains a variety of gas and particulate matter constituents, including black carbon,
organic carbon, nitrate, carbon monoxide, non-methane volatile organic compounds, sulfate,
ammonium, alkanes, naphthalenes, phenanthrenes, and various polyaromatic hydrocarbons.
In addition, the relative composition of the exhaust is significantly influenced by fuel type,
engine type and condition, engine operation, engine load, and pretreatment (eg, particle
traps) of exhaust.76 Certain occupations (eg, underground miners, truck and bus drivers, toll
booth attendants, construction workers) are known to have increased risk of exposure to
diesel exhaust, with documented higher exposures of elemental carbon associated with
enclosed underground mining and construction operations.77 There is also widespread diesel
engine exhaust exposure to the general population.
Diesel engine exhaust had been listed by the IARC since 1998 as possibly carcinogenic to
humans (Group 2B).78 Because of increasing epidemiologic evidence, however, originating
from a variety of occupational settings, that exposure to diesel engine exhaust is a human
carcinogen, the IARC convened a working group to review the existing evidence.79 After
review of the available information, the IARC work group added diesel engine exhaust as a
Group 1 carcinogen on June 12, 2012 (Fig. 3).80 Although the specific findings supporting
their decision had not yet been published in monograph form at the time of this writing, the
IARC indicated that their decision was based on the mounting evidence,81 including 2 meta-
analyses and a pooled epidemiologic study, that diesel engine exhaust is a known human
lung carcinogen. The IARC specifically mentioned the recent results of a nested study
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performed by Silverman and colleagues82 within a cohort of workers from 8 nonmetal
mining facilities that provided strong support for the lung carcinogenicity of diesel engine
exhausts.
The study by Silverman and colleagues,82 which included 198 lung cancer deaths, reported a
statistically significant positive trend between estimated respirable elemental carbon
exposure (used as a marker of the mixed particulate and gaseous components of diesel
exhaust), lagged 15 years, and a statistically significant increased lung cancer risk (P = .001)
after adjustment for smoking and other potential confounders. For workers with heavy
exposure to respirable elemental carbon (ie, above the median of the top quartile [respirable
elemental carbon ≥1005 μg/m3 – y]), the reported risk was approximately 3 times greater
(OR = 3.20, 95% CI = 1.33–7.69) as compared with workers in the lowest quartile of
exposure. The effect of cigarette smoking among study subjects was attenuated among
workers with higher past diesel exposure estimated using respirable elemental carbon. Dr
Kurt Straif, head of the IARC Monographs Program, stated that although IARC’s
conclusions regarding the lung carcinogenicity of diesel engine exhaust were based on
rigorous epidemiologic studies of highly exposed workers, “we have learned from other
carcinogens, such as radon, that initial studies showing a risk in heavily exposed
occupational groups were followed by positive findings for the general population.
Therefore actions to reduce exposures should encompass workers and the general
population.”80 For additional information on the lung cancer risk associated with diesel
exposure, see http://www.iarc.fr/en/media-centre/iarcnews/2012/mono105-
backgrounderQ_A.php.
IARC GROUP 1 LUNG CARCINOGENS: OCCUPATIONS AND
MANUFACTURING PROCESSES
The 2009 IARC work group determined that there was sufficient evidence in humans for the
carcinogenicity of occupational exposures occurring during work activities in the following
6 discrete occupational categories83:
• Coal gasification
• Coke production
• Iron and steel founding
• Aluminum production
• Painting
• Rubber production industry
Coal Gasification, Coke Production, Iron and Steel Founding, Aluminum Production
The occupational groupings of coal gasification, coke production, iron and steel founding,
and aluminum production, all have potential for high exposure to PAHs, as well as to other
chemicals, especially in the 1950s to 1990s when many of the occupational cohort
epidemiologic studies were performed. The evidence for the positive dose-response
relationship noted for many of the cohort studies, which were cited by the IARC83 to help
establish the evidence for the carcinogenicity of that occupational grouping, used
benzo(a)pyrene as a surrogate exposure measure of PAHs. It is noteworthy that although
IARC has not listed benzo(a)pyrene as a lung carcinogen based on epidemiologic data, it has
listed benzo(a)pyrene as a Group 1 carcinogen based on mechanistic and experimental
animal studies indicating that it is likely to be a human carcinogen.
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In a combined study of cohorts of workers exposed to PAHs published in 2007, Bosetti and
colleagues84 reported a pooled relative risk of 1.51 (95% CI 1.28–1.78) for roofers, 2.58
(95% CI 2.28–2.92) for coal gasification, 1.58 (95% CI 1.47–1.69) for coke production, and
1.40 (95% CI 1.31–1.49) for iron and steel foundries. A non–statistically significant pooled
relative risk of 1.03 (95% CI 0.95–1.11) was found for aluminum production workers. For
additional information on the lung cancer risk posed by coal gasification, coke production,
iron and steel founding, and aluminum production, see http://monographs.iarc.fr/ENG/
Monographs/vol100F/index.php.
Painting
The increased use of water-based paints and the intentional reduction of some of the toxic
agents in paints, such as benzene, phthalates, lead oxides, and chromates, have reduced the
risk of adverse health outcomes related to painting. Nonetheless, painters continue to have
the potential for exposure to hundreds of hazardous chemicals (eg, dichloromethane,
diisocyanates, amines, esters, chromates, nickel, ketones).85 For additional details, see http://
monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-35.pdf.
More than 50 epidemiologic studies (ie, cohort and case-control) were published between
1951 and 2010 that overall demonstrate a relatively consistent increased risk for painters. A
2010 meta-analysis based on census reports, and case-control and cohort studies published
through 2008,86 reported a summary risk estimate for lung cancer among painters of 1.29
(95% CI 1.10–1.51) for case-control studies and 1.22 (95% CI 1.16–1.29) and 1.36 (95% CI
1.34–1.41) for lung cancer incidence and mortality studies, respectively. A second large
meta-analysis published in 2010,87 which included more than 11,000 incident lung cancer
cases or deaths among painters, reported a summary risk estimate for lung cancer of 1.35
(95% CI 1.29–1.41) and 1.35 (95% CI 1.21–1.51) after controlling for smoking. In addition,
the exposure-response relationship suggested the risk increased with duration of
employment. For additional information on the lung cancer risk associated with painting as a
profession, see http://monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-35.pdf.
Rubber Manufacturing Industry
Rubber production workers are exposed to fumes with a complex chemical composition
generated during the heating and curing of rubber compounds. The cyclohexane-soluble
fraction of fumes often serves as an indicator to assess total particulate fume
contamination.88 In addition, high concentrations of nitrosamines are formed in rubber
manufacturing during the vulcanizing process.89,90 Furthermore, other likely exposures
include carbon black, asbestos-contaminatedtalc, solvents, phthalates, and PAHs.88,91
The 2009 IARC work group concluded that there was sufficient evidence in humans for the
carcinogenicity of occupational exposures in the rubber-manufacturing industry based in
large part on retrospective cohort mortality studies that reported increased lung cancer risks
among rubber workers involved with mixing and milling, vulcanization, tire-curing
departments, and in cohorts of workers exposed to high concentrations of fumes and/or
solvents.88 Overall, there has been a high degree of heterogeneity of findings for both cohort
and case-control studies. A 2006 meta-analysis that included 24 cohort studies of workers in
the synthetic rubber-producing industry92 reported a summary Standardized Mortality Ratio
(SMR) of 1.05 (95% CI 0.94–1.18). Several other recent cohort studies of rubber workers
performed in Germany, the United Kingdom, and Italy reported similar findings.93–95 It is
unknown to what extent these recent studies were affected by the Healthy Worker Effect.
For additional information on the lung cancer risk associated with rubber manufacturing, see
http://monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-36.pdf.
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IARC GROUP 1 LUNG CARCINOGENS: METALS
Arsenic and Inorganic Arsenic Compounds
Arsenic, a chemical element classified as a metalloid, is both an environmental and
occupational lung carcinogen. The most common forms of arsenic in the environment are
arsenite and arsenate. Arsenic compounds linked with carbon and hydrogen are considered
organic; those combined with oxygen, chlorine, sulfur, and so forth, but without carbon are
considered inorganic. Occupational exposures occur primarily among workers who breathe
dust from lead, gold, and copper ore mines and smelters. Another potential source of
exposure that has diminished in the past 10 years owing to declining use, occurred during
the production and application of arsenical insecticides (eg, lead arsenate, calcium arsenate),









Sources of airborne exposures include emissions from smelting of metals (eg, nickel copper
smelters), from insecticide/herbicide application, and natural releases from volcanic sources.
A significant source of human exposure occurs from consumption of fish and seafood.96
Over the past 10 years, a major source of environmental exposure of concern with regard to
lung cancer is drinking water containing arsenic from groundwater sources.
In addition to studies of historical exposure from pesticidal and pharmaceutical uses, the
2009 IARC work group reviewed a large body of findings from 2 primary routes of arsenic
exposure: occupational groups who had exposure to a mixture of inorganic arsenic
compounds in contaminated air and nonoccupational studies of individuals who ingested
arsenic (ie, arsenite and arsenate) in drinking water over a protracted period. The IARC
concluded that the cohort and nested case-control studies provided fairly consistent
exposure-response evidence that arsenic exposure via inhalation increases (eg, Standardized
Mortality Ratio (SMR) range 2–3) lung cancer risk97; however, the quality of the exposure
data for inorganic arsenic did not allow a separation of the risk based on a particular arsenic
species. In a study of more than 8000 Montana copper smelters employed through 1989,
Lubin and colleagues98 reported a linear exposure-response between cumulative estimated
inhaled inorganic arsenic and respiratory cancer mortality. The person-year–weighted mean
cumulative arsenic exposure was 3.7 mg/m3-years with a reported SMR for respiratory
cancer of 1.56 (95% CI 1.4–1.7). The investigators also noted that “inhalation of higher
concentrations of arsenic over shorter durations was more deleterious than inhalation of
lower concentrations over longer durations.”
The IARC detailed the results of numerous ecologic studies and case-control studies
performed in Argentina, Bangladesh, Chile, and Taiwan that examined the associations
between higher concentrations (eg, >100 μg/L) of arsenic in drinking water and lung cancer.
Overall, the ecologic (eg, studies that use aggregate or summary data to assess both
exposure and often adverse health outcomes) studies reported significantly increased risks
with increasing estimated levels of arsenic exposure.97 A case-control study performed by
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Ferreccio and colleagues99 reported ORs of 1.0, 1.6 (95% CI 0.5–5.3), 3.9 (95% CI 1.2–
12.3), 5.2 (95% CI 2.3–11.7), and 8.9 (95% CI 4.0–19.6) for long-term exposure to ingested
waterborne arsenic concentrations of less than 10, 10 to 29, 30 to 49, 50 to 199, and 200 to
400 μg/L, respectively. The investigators also observed a synergistic (ie, greater than
additive) effect between waterborne arsenic concentrations and smoking.
Studies examining the association between drinking water with lower concentrations of
arsenic and lung cancer are less supportive of an association between ingested arsenic in
drinking water and lung cancer. It is not known if the lack of evidence of an association
below 100 μg/L is the result of a threshold effect or an attenuation of the observed risk from
nondifferential exposure misclassification.100 Because of the large population at risk from
exposure to arsenic in their drinking water, arsenic exposure may represent a substantial
public health problem if a risk threshold does not exist. For additional information on the
lung cancer risk posed by exposure to arsenic and arsenic compounds, see http://
monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-6.pdf.
Beryllium and Beryllium Compounds
Beryllium is a silver-gray metallic divalent element that occurs naturally in the earth’s
crust.101,102 Airborne concentrations are generally low and originate primarily form
windblown dusts. Higher atmospheric concentrations of beryllium have been detected in the
vicinity of coal-generating plants, municipal waste incineration, and beryllium ore
processing and production plants,101,102 and between 1959 and 1970 near the burning of
solid rocket fuel.103 The United States, China, and Kazakhstan are the only countries
currently involved in the industrial-scale extraction of beryllium.104
A large proportion of the beryllium manufactured is in the form of copper-beryllium alloys.
High rigidity, thermal stability, thermal conductivity, low density, and antispark properties






• Automotive (eg, antilock breaking systems)
• Consumer products (eg, camera shutters)
• Energy and electrical
• Tools
• Sporting goods (eg, golf clubs)
• Electronics, biomedical (eg, dental braces and bridges, x-ray tube windows)
• Jewelry
• Scrap recovery and recycling
• Defense
• Nuclear industries
Kreiss and colleagues105 estimated that more than 134,000 US workers have been exposed
to beryllium. Beryllium that is inhaled may slowly dissolve in the lungs and move into the
Field and Withers Page 11













bloodstream. Some beryllium may be expectorated from the lungs and swallowed, although
once engulfed by macrophages the particles have clearance rate half-times of hundreds to
thousands of days.106,107 The IARC has classified beryllium as a Group 1 known human
carcinogen since 1981. The IARC based its 1993 review of the lung carcinogenicity of
beryllium primarily on studies from US Beryllium Case Registry cases and from the
findings of a cohort study of 9225 workers employed at 7 beryllium-processing plants.108 In
the 2009 IARC working group assessment of the lung carcinogenicity of beryllium,102 the
work group references a nested case-control study performed by Schubauer-Berigan and
colleagues109 that included 142 lung cancer cases each matched to 5 controls as supporting
the lung carcinogenicity of beryllium. The investigators reported a significant relationship
between average, but not cumulative, beryllium exposure and lung cancer risk after
adjusting for birth year. Even though the study was criticized for methodological issues
related to selection of controls,110 the IARC working group noted that the criticisms did not
undermine their confidence in the findings referencing several publications that supported
the methodology used in the analyses.102
Two subsequent studies by Schubauer-Berigan and colleagues111,112 published since the
IARC’s 2009 review provide further support for the lung carcinogenicity of beryllium. The
first study111 extended the mortality follow-up (1940 through 2005) for 9199 workers from
the 7 beryllium-processing plants. The study reported elevated lung cancer rates as
compared with the US population (SMR 1.17, 95% CI 1.08–1.28) and intracohort analysis
found that workers with maximum beryllium exposure of 10 μg/m3 or higher had higher
rates of lung cancer. Positive trends with cumulative beryllium exposure were observed for
lung cancer (P = .01) when short-term workers were excluded. The second study performed
by Schubauer-Berigan and colleagues112 examined the shape of exposure-response
associations between various exposure metrics and lung cancer, while adjusting for potential
confounders (ie, race, plant, professional and short-term work status, and exposure to other
lung carcinogens). The investigators reported positive associations between lung cancer and
mean (P<.0001) and maximum (P<.0001) beryllium exposure with adjustment for age, birth
cohort, and plant, as well as positive associations for cumulative (P = .0017) beryllium
exposure with adjustment for the previous factors plus short-term work status and exposure
to asbestos.
Despite IARC’s listing of beryllium as a Group 1 carcinogen, some researchers continue to
reject the validity of the science on which the IARC based their decision, as well as the
validity of the findings from the recent studies by Schubauer-Berigan and colleagues.111,112
In a review of epidemiologic data, supported by an unrestricted grant from Materion Brush,
Inc, Boffetta and colleagues113 assert that most epidemiologic studies examining the
association between beryllium exposure and lung cancer have likely failed to adequately
address confounding by smoking and other occupational and lifestyle factors, claiming,
“Overall, the available evidence does not support a conclusion that a causal association has
been established between occupational exposure to beryllium and the risk of cancer.” For
additional information on the lung cancer risk posed by exposure to beryllium and beryllium
compounds, see http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-7.pdf.
Cadmium and Cadmium Compounds
Cadmium is a soft, bluish-white metal recovered as a by-product of zinc mining and
refining. The zinc-to-cadmium ratios in most zinc ores range from 200:1 to 400:1.114
Cadmium use has decreased over time, except with its use in nickel-cadmium batteries,
“silver solder” containing cadmium, and cadmium-telluride solar panels. These declines
have come about because of its toxicity, the resulting regulations, and alternate
technologies.115 This decrease in consumption was offset by the increased demand for
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cadmium in nickel-cadmium batteries, which accounted for 81% of the cadmium used as of
2006 in the United States.114
Environmental exposures to cadmium are primarily the result of volcano emissions, fossil
fuel and wood combustion, forest fires, phosphate fertilizers, iron and steel production
emissions, cement production and use, releases from phosphoric acid processes, smelting of
nonferrous metals production, and municipal solid waste incineration.96 In addition,
cigarettes contain varying concentrations of cadmium (in the microgram level) and
approximately 10% of the cadmium is inhaled when a cigarette is smoked.115
The primary route of cadmium exposure in work areas is via the respiratory tract. The
highest potential for occupational exposures occurs during the following work
processes115,116:
• Welding or remelting cadmium-coated steel
• Smelting zinc and lead ores




• Processing, producing, and handling cadmium powders
In 2010, Alaska, Idaho, Missouri, and Tennessee produced zinc concentrate containing
cadmium; cadmium metal was produced at a primary electrolytic zinc refinery at the
Clarksville refinery in Tennessee and at secondary smelters in Ohio and Pennsylvania.117
Cohort epidemiologic studies of workers in the nickel alloy, nickel smelting, and nickel-
cadmium battery operations that were performed primarily between 1976 and 1998, as well
as findings from a prospective population-based study in a cadmium-contaminated area in
Belgium, formed the basis for the IARC’s decision to classify cadmium and cadmium
compounds as Group 1 carcinogens.118 The 2009 IARC working group noted that
interpretation of findings from cohorts exposed are limited by small numbers of workers
with high long-term exposures, a scarcity of cadmium exposure data, ability to compare
exposure gradients between studies, and difficulty accounting for possible confounding by
smoking. Among studies published since the IARC’s 2009 review, Beveridge and
colleagues119 reported an increased OR of 4.7 (95% CI 1.5–14.3) only among former or
nonsmokers with exposure to cadmium in 2 population-based case control studies in
Montreal. Cadmium exposure did not produce an observable increased risk among smokers,
however. Park and colleagues120 recently reported findings from a reanalysis of cadmium
smelter workers that incorporated a retrospective exposure assessment for arsenic (As),
updated mortality information for 1940 to 2002, a revised cadmium exposure matrix, and
improved work history information. The investigators reported an increased lung cancer risk
from airborne cadmium exposure independent of arsenic exposure (SMR = 3.2 for 10 mg-
year/m3 cadmium, P = .012). For additional information on the lung cancer risk posed by
exposure to cadmium and cadmium compounds, see http://monographs.iarc.fr/ENG/
Monographs/vol100C/mono100C-8.pdf.
Chromium (VI) Compounds
Chromium is the 21st most abundant element in the earth’s crust, occurring mainly in a
trivalent state; however, hexavalent chromium (chromium VI) compounds are classified as
Group 1 lung carcinogens and are produced primarily from industrial processes. OSHA
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classifies chromium (VI) compounds by their water solubility, specifically as follows: water
insoluble (solubility <0.01 g/L), slightly soluble (solubility 0.01 g/L–500 g/L), and highly
water soluble (solubility ≥500 g/L).121 Exposure to chromium (VI) trioxide results in
damage to the nasal mucosa and possible perforation of the nasal septum, whereas exposure
to insoluble chromium (VI) compounds results in damage to the lower respiratory tract.122
The Agency for Toxic Substances and Disease Registry reports that about 9000 tons of
chromium (VI) are released to the air each year in the United States.122 The potential for
airborne environmental exposure to chromium (VI) compounds is higher for individuals
living near anthropogenic sources of chromium production.122 Although studies based on
aggregate measures of exposure and lung cancer outcome (ie, ecologic studies) have been
published suggesting an association between environmental exposure to chromium exposure
and lung cancer, these types of studies are reserved for hypothesis generating rather than
assessing risk.123
Based on a 2006 OSHA contractor’s report,124 the following US industries with the highest





• Iron and steel foundries
• Paint and coating production
• Plastic colorant production and use
• Chromium catalyst production
• Chromate chemical production
• Plating mixture production
• Printing ink production
• Chromium metal producers
• Chromate pigment production
• Chromated copper arsenate production
The IARC concluded from a review of more than 25 cohort studies published between 1952
and 2006 that there was sufficient evidence in humans for the lung carcinogenicity of
chromium (VI) compounds, especially for highly exposed workers in the chromate
production, chromate pigment production, and chromium-plating industries.125 The 2009
IARC working group pointed out that because of the mixed exposures workers received and
the increased lung cancer risk observed in diverse industries that exposed workers to varying
chromium (VI) compounds, the IARC recommended that the broad category of chromium
(VI) be listed a Group 1 carcinogen.
Studies of workers with lower estimated exposures of chromium (VI) that have been
published since 2000 have produced mixed results. For example, a recent pooled analysis of
2 case-control studies of Montreal workers exposed to lower estimated concentrations (ie,
exposed/unexposed) of chromium (VI) reported ORs of 2.4 (95% CI 1.2–4.8) for
nonsmoking, chromium (VI)–exposed workers versus 1.0 (95% CI 0.7–1.3) for chromium
(VI)–exposed workers who smoked.119,125 It should be noted that the results for the
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nonsmoking workers were based on findings from only 46 controls and 12 cases. For
additional information on the lung cancer risk posed by exposure to chromium (VI)
compounds, see http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-9.pdf.
Nickel Compounds
Nickel is a silvery white metal that occurs naturally, as the 24th most abundant element, in
the earth’s crust, generally accompanying sulfide and silica-oxides ores. The mining of these
ores, which contain less than 3% nickel, occurred in the United States from the late 1950s to
1998.126–128 New US nickel-mining sites have been developed in Minnesota and Michigan.
The potential for low-level atmospheric nickel exposure arises from natural sources (eg,
windblown dust, volcanoes, forest, and wildfires) and anthropogenic activities (eg, mining,
refining, smelting, manufacture of nickel-containing alloys and stainless steel, fossil fuel
combustion, waste incineration).129 The EPA estimates that in 2007, 1027 facilities released
30.5 million pounds of nickel compounds127; however, atmospheric concentrations of nickel
compounds in the United States are reported to be 100,000 to 1 million times lower than the
concentrations reported to increase cancer rates.130 Although studies have shown an
association between aggregate measures of environmental exposure to nickel compounds
and lung cancer, these types of studies (ie, ecologic studies) are generally reserved for
hypothesis generating rather than testing.123
Occupations that have the potential for exposure to nickel compounds include126–130 the
following:
















• Organic chemical synthesizers
• Paint makers
• Petroleum refinery workers
• Stainless-steel makers
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• Vacuum tube makers
• Varnish makers
• Welders
The primary evidence demonstrating the human lung carcinogenicity of nickel compounds
and nickel metal is based on epidemiologic findings from nickel refinery and nickel smelter
workers. The 2009 IARC working group concluded,129 after a detailed review of pertinent
epidemiologic studies, that strong evidence for the carcinogenicity of nickel compounds
exists for nickel chloride,131 nickel sulfate, water-soluble nickel compounds in
general,131,132 insoluble nickel compounds, nickel oxides,131,133 nickel sulfides,134 and
mostly insoluble nickel compounds.133
The investigators135 of a study funded by Nickel Producers Environmental Research
Association contend that, in addition to lack of adequate control for confounding, the
epidemiologic studies focusing on soluble nickel compounds cannot differentiate between
nickel compounds, and therefore some of the increased risk attributed to soluble nickel
compounds may be from other nickel species. However, the IARC129 cites the studies of
Norwegian refinery workers131,132,136 to support the basis for the human lung
carcinogenicity of soluble nickel because of the availability of cigarette smoking data and
the adjustments that were performed to reduce potential confounding. The IARC’s129 2009
evaluation of nickel as a lung carcinogen concludes that there is “sufficient evidence in
humans for the carcinogenicity of mixtures that include nickel compounds and nickel metal.
The evidence is strongest for soluble nickel compounds; there is also independent evidence
for the carcinogenicity of oxidic and sulfidic nickel compounds.”
The IARC’s position is further supported by a recent study by Grimsrud and Andersen137
who assert that the claimed absence of nickel-related respiratory cancer among electrolysis
workers resulted from “an arbitrary overemphasis of biased and inconclusive findings” by
some researchers.135 Another recent case-control study performed in Italy138 that used a
lifetime job exposure matrix, estimated an OR of 1.18 (95% CI 0.90–1.53) among workers
with relatively low exposures of combined nickel-chromium exposure (eg, metal
mechanics). For additional information on the lung cancer risk posed by exposure to nickel
compounds, see http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-10.pdf.
IARC GROUP 1 LUNG CARCINOGENS: DUST AND FIBERS
Asbestos (All Forms)
Asbestos is a naturally occurring fibrous silicate mineral that exists in 2 forms: serpentine
(ie, chrysotile) and amphibole (ie, actinolite, amosite, anthophyllite, crocidolite, and
tremolite). Chrysotile, anthophyllite, amosite, and crocidolite asbestos have been used
commercially.139 Widespread application of asbestos materials in various settings in the
United States did not occur until the early 1930s; however, by 1980, the construction
industry accounted for more than two-thirds of the total asbestos demand.
A 1989 EPA ban on most asbestos-containing products was overturned in 1991 by a federal
court; however, a ban continues on several items (eg, flooring felt, roll board, and certain
types of specialty paper), as well as for products that have not historically contained
asbestos, otherwise referred to as “new uses” of asbestos.140 Asbestos is not currently mined
in the United States, and the use of asbestos in 2011 was similar to the level (ie, 1000 ton/y)
of use in 1909.141 Most of the asbestos currently used in the United States, which is
primarily chrysotile asbestos, is imported from Canada.141
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Because of the past widespread use of asbestos-containing products, the potential for
exposure is widespread, but nonetheless has decreased each year since the partial ban. The
primary sources of exposure for members of the general public include releases of asbestos
(eg, friable asbestos-containing building materials and insulation) from older buildings,
brake linings, demolition of older buildings, living near asbestos-containing waste sites or
asbestos-related industries, asbestos-contaminated vermiculite, exposure to poorly contained
asbestos removal operations, and exposure to talc containing asbestiform fibers.142,143
“Bystander exposure” to asbestos fibers can also take place by contact with asbestos workers
or their clothes.
Occupational exposures in the past were much more prevalent and included142–144 the
following:
• Asbestos mining and processing operations
• Talc mining and processing (talc containing asbestiform fibers)
• Asbestos insulation
• Textile work
• The manufacture of asbestos-containing products
• Ship building
• Construction
• Numerous other industries
Occupational exposures still occur among workers who work with asbestos-containing end
products,142–144 including the following occupations:
• Asbestos insulation workers
• Automotive repair and maintenance workers
• Building maintenance workers
• Building demolition workers and abatement workers (eg, materials: roof shingles,
drywall, flooring, cement, fireproofing, insulation)
The 3 lung-specific adverse health outcomes associated with exposure to asbestos are
asbestosis, lung cancer, and mesothelioma (which can be of the pleura as well as the
peritoneum, but is not further considered in this review of lung cancer). A long-standing
controversy not addressed in a substantive manner by the IARC137 is whether the risk of
lung cancer is associated with asbestos exposure alone and/or asbestosis.14,143 The 2009
IARC working group concluded that all forms of asbestos cause lung cancer,144 however,
while acknowledging that controversies remain regarding the potency differences for fibers
of different types (eg, low potency of chrysotile versus high potency of amphiboles)145–147
and dimensions (eg, lower potency of shorter and wider fibers versus higher potency of
thinner and longer fibers).148,149
The 2009 IARC working group indicated that some of the heterogeneity in findings between
studies may not be related to differences in potency for different fiber types, but rather
differences in rigor of exposure assessment. The investigators of a meta-analysis published
in 2011 reported150 that studies with higher-quality asbestos exposure data produced higher
meta-estimates of the lung cancer risk per unit of exposure and that discerning potency
differences between chrysotile versus amphibole asbestos–exposed cohorts was more
challenging when the meta-analyses are limited to a smaller number of studies with
questionable exposure assessment methods.
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Nonetheless, several studies151,152 reported an increased risk for lung cancer associated with
chrysotile asbestos exposure. In a retrospective cohort study of 5770 textile workers in
North Carolina, Loomis and colleagues153 reported an SMR of 1.96 (95% CI 1.7–2.2) for
lung cancer. In addition, a 2008 retrospective cohort study of 3072 workers at a South
Carolina textile plant reported that lung cancer was most strongly associated with exposure
to thin (<0.25 μm) and longer (>10 μm) fibers. A recent pooled analysis154 of 3717 men and
2419 women employed at any of the 4 textile mills in North or South Carolina before 1973
reported a pooled relative rate for lung cancer of 1.11 (95% CI 1.06–1.16) when comparing
exposures at 100 f-y/mL to 0 f-y/mL. A subsequent analysis155 found that whereas lung
cancer mortality was associated with particles of any size, exposure to longer (ie, >5–10 μm)
and thinner (<0.25 μm) fibers presented a greater risk. For additional information on the
lung cancer risk posed by exposure to asbestos, see http://monographs.iarc.fr/ENG/
Monographs/vol100C/mono100C-11.pdf.
Silica Dust, Crystalline, in the Form of Quartz or Cristobalite
Silicon is the second most common element in the Earth’s crust. Two allotropes of silicon,
amorphous and crystalline, exist at room temperature. The compound silica, also known as
silicon dioxide (SiO2), makes up more than 25% of the Earth’s crust. Amorphous silica
usually occurs as a brown powder as compared with the metallic luster and a grayish color
of crystalline silica.156 Crystalline silica exists as quartz, cristobalite, tridymite, and 4 other
very rare forms (ie, keatite, coesite, stishovite, and moganite).157 Quartz is the most
common form of crystalline silica and the primary component of sand and of dust in the
air.156
Environmental exposures to silica can arise from natural (eg, forest fires, volcanic eruptions,
wind erosion) and anthropogenic activities (eg, construction, gravel roads, demolition,
quarrying, mining, and farming activities—tilling). The potential for occupational exposure
to silica is widespread. Potential occupational exposures to silica include a wide variety of
occupations and industries,157–159 including the following:
• Oil and gas extraction
• Bituminous coal and lignite mining
• Mining and quarrying of nonmetallic minerals (except most fuels) including silica
sand mining
• Hydraulic fracturing for natural gas development (Fig. 4)
• Metal mining
• Masonry, stonework, tile setting, and plastering
• Services to dwellings and other buildings
• Concrete, gypsum, and plaster products
• Roofing and sheet metal work
• Construction (eg, bridge, tunnel, and elevated highway)
• Agricultural activities
• Wrecking and demolition activities
• Medical and dental laboratories work
• Foundry work (ferrous and nonferrous)
• Vitreous enameling
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• Manufacturing of soaps and detergents
• Shipyard work
• Railroads
• Automotive repair shops
• Production of pottery and related items
The 2009 IARC working group’s reaffirmation of the lung carcinogenicity of silica focused
on the epidemiologic findings from 5 primary occupational settings: ceramics, diatomaceous
earth, ore mining, quarries, and sand and gravel.159 Among these industries, the IARC
assumed sand and gravel operations, quarries, and diatomaceous earth facilities had the least
potential for confounding and reported that studies with quantitative exposures generally
report increased lung cancer rates with increasing exposure to crystalline silica. However,
the IARC indicates the strongest evidence supporting the lung carcinogenicity of crystalline
silica was from the pooled epidemiologic studies160,161 that revealed a clear exposure-
response relationship and an overall increased lung cancer risk for the meta-analyses from a
diverse number of industries.162,163 Debate continues that the inflammation caused by
crystalline silica exposure, and perhaps the resulting silicosis, is the driving force for the
development of cancer.162,164–166 For additional information on the lung cancer risk posed
by exposure to silica dust, crystalline, in the form of quartz or cristobalite, see http://
monographs.iarc.fr/ENG/Monographs/PDFs/index.php.
IARC GROUP 2 LUNG CARCINOGENS
Group 2–listed human lung carcinogens include the following:
• Acid mists, strong inorganic
• Art glass, glass containers, and pressed ware (manufacture of)
• Biomass fuel (primarily wood) indoor emissions from household combustion of
• Bitumens, oxidized, and their emissions during roofing
• Bitumens, hard, and their emissions during mastic asphalt work
• Carbon electrode manufacture
• alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and
benzoyl chloride (combined exposures)
• 2,3,7,8-tetrachlorodibenzo-para-dioxin
• Cobalt metal with tungsten carbide
• Creosotes
• Frying, emissions from high temperature
• Insecticides, nonarsenical (occupational exposures in spraying and application)
• Printing processes (occupational exposures in)
• Welding fumes
Scientific evidence is also mounting that other Group 2 human lung carcinogens167 should
receive greater consideration as Group 1 carcinogens. Fortunately, several potential lung
carcinogens (eg, welding; motor vehicle emissions; carbon-based nanoparticles; crystalline
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fibers other than asbestos; outdoor air pollution, including sulfur oxides, nitrogen oxides,
ozone, and dusts; ultrafine particles) are listed as priority agents for future review.168
SUMMARY
The IARC’s updated assessments, published in 2012 as Volume 100 C through F of the
IARC Monographs, provide a long overdue resource for consensus opinions on the
carcinogenic potential of various agents. Unfortunately, many of the studies reviewed by
IARC, which attempted to identify whether or not a causal association existed between
various exposures and lung cancer, were often impeded by confounding from smoking and
poor retrospective exposure assessment. As pointed out in the President’s Cancer Panel’s
2010 report,16 research on environmental and occupational causes of cancer have been
limited by low priority and inadequate funding. This is especially true for lung cancer
research. The large percentage of lung cancer deaths caused by smoking often obscures the
fact that nonsmoking-related lung cancer is 1 of the top 10 causes of cancer mortality and, in
some cases (eg, medically related radiation exposures, radon), the attributable risk of the
agent is increasing. The foregoing data also underscore that in the clinical assessment of
lung cancer risk, ascertaining past occupational exposures as well clarifying selected
environmental risks should hold an equal place to quantifying cumulative cigarette smoking
in pack years.
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• If considered independently from tobacco smoking, environmentally and
occupationally related causes of lung cancer are among the top 10 causes of
cancer mortality in the United States.
• The goal of this review was to describe the occurrence and recent findings of the
27 agents currently listed by the International Agency for Research on Cancer
(IARC) as lung carcinogens, including the categories of ionizing radiation,
chemicals and mixtures, occupational exposures, metals, dust and fibers,
personal habits, and other exposures.
• Supplementary new information, with a focus on analytic epidemiologic studies
that have become available since IARC’s most recent evaluation, is also
discussed.
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Percentage of total effective dose for the average individual in the US population from
various radiation sources. Percent values rounded to the nearest 1%, except for those <1%.
(Reprinted with permission of the National Council on Radiation Protection and
Measurements, http://NCRPpublications.org.)
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Estimated number of cancer deaths in the United States for 2012. (Source: http://
onlinelibrary.wiley.com/doi/10.3322/caac.20138/full#fig1.)
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The International Agency for Research on Cancer added diesel engine exhaust to the list of
Group 1 carcinogens in 2012. (Courtesy of Centers for Disease Control/The National
Institute for Occupational Safety and Health (NIOSH).)
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Worker exposure to silica during hydraulic fracturing. Silica dust created by worker
conducting sand transfer operations. Photo shows sand mover and transfer system. (Courtesy
of Centers for Disease Control/The National Institute for Occupational Safety and Health
(NIOSH).)
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Table 1
Group 1 IARC carcinogens with sufficient evidence of causing lung cancer in humans and primary type of
exposure
Agent Primary Exposure Type
Ionizing radiation-all types
• Alpha-particle emitters E,O
  ○ Radon-222 and its decay products E,O
  ○ Plutonium-239 O
• X-radiation, gamma-radiation E,O
Chemicals and mixtures
• Bis(chloromethyl)ether; chloromethyl methyl ether O
• Coal-tar pitch O
• Soot O
• Sulfur mustard O
• Diesel exhausts E,O
Occupations
• Aluminum production O
• Coal gasification O
• Coke production O
• Hematite mining (underground) O
• Iron and steel founding O
• Painting O
• Rubber production industry O
Metals
• Arsenic and inorganic arsenic compounds E,O
• Beryllium and beryllium compounds O
• Cadmium and cadmium compounds O
• Chromium (VI) compounds O
• Nickel compounds O
Dust and fibers
• Asbestos (all forms) E,O
• Silica dust, crystalline E,O
Personal habits
• Coal, indoor emissions from household combustion E
• Tobacco smoke, secondhand E,O
Other exposures
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Agent Primary Exposure Type
• Tobacco smoking —
• MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) —
Abbreviations: E, environmental exposure; IARC, International Agency for Research in Cancer; O, occupational exposure.
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